Subscribe
Models
Our Products
Featured Catalog
Humanized Mouse Models
Tool Mice
Custom Model Services
Preclinical Solutions
Resources
About Us
hCRBN/Rag2-KO(BALB/c) Mouse
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
hCRBN/Rag2-KO(BALB/c) Mouse
Product Name
hCRBN/Rag2-KO(BALB/c) Mouse
Product ID
C002136
Strain Name
BALB/cAnCya-Crbnem1(hCRBN)Rag2em1/Cya
Background
BALB/cAnCya
Status
When using this mouse strain in a publication, please cite “hCRBN/Rag2-KO(BALB/c) Mouse (Catalog C002136) were purchased from Cyagen.”
Tumor Target Humanized Mouse ModelsImmune Target Humanized Mouse ModelsOther Immunodeficient Mice
ADC
AOC
Gene Editing Therapy
PROTAC & Molecular Glue
CDS Humanized Models
Product Type
Age
Genotype
Sex
Quantity
The standard delivery applies for a guaranteed minimum of three heterozygous carriers. Breeding services for homozygous carriers and/or specified sex are available.
+
Standard products are sold as live mice derived from cryorecovery or expansion. Frozen materials are available upon request. Pricing and lead times depend on real-time inventory.
Tumor Target Humanized Mouse ModelsImmune Target Humanized Mouse ModelsOther Immunodeficient Mice
ADC
AOC
Gene Editing Therapy
PROTAC & Molecular Glue
CDS Humanized Models
Basic Information
Related Resource
Basic Information
Gene Name
Rag2 & CRBN
Gene Alias
Rag-2, MRT2, MRT2A
NCBI ID
Chromosome
Chr 2 (Mouse), Chr 3 (Human)
MGI ID
Datasheet
Strain Description
The CRBN gene is located on human chromosome 3 and is broadly expressed across multiple tissues, with particularly prominent expression in brain tissue, kidney parenchyma, skeletal muscle, and various immune cell populations, including monocytes, macrophages, dendritic cells, and B lymphocytes [1]. The Cereblon protein encoded by this gene serves as a critical substrate recognition receptor of the CRL4-CRBN E3 ubiquitin ligase complex, playing an important regulatory role within cells. This complex specifically recognizes target proteins and mediates their ubiquitination, subsequently directing these proteins into the proteasomal degradation pathway, thereby precisely regulating multiple fundamental cellular processes, including protein homeostasis, ion channel transport activity, and AMPK signaling pathway transduction [1-2]. In the field of genetic disease research, it is well established that loss-of-function mutations in the CRBN gene are closely associated with the pathogenesis of non-syndromic intellectual disability with an autosomal recessive inheritance pattern [2]. Furthermore, as the primary molecular target of targeted protein degradation (TPD) therapy, the Cereblon protein can induce selective degradation of specific transcription factors by modulating the enzymatic activity of the CRL4-CRBN complex and altering its substrate recognition properties. This molecular mechanism has become an important theoretical foundation for the clinical treatment of malignant hematological diseases such as multiple myeloma, giving rise to various drug types, including molecular glues and proteolysis-targeting chimeras (PROTACs) [3-5].
The protein encoded by the RAG2 gene, together with the RAG1 protein, constitutes the RAG complex, which plays an essential role in V(D)J recombination during the maturation of B cells and T cells. During V(D)J recombination, the RAG complex attaches to recombination signal sequences (RSS) on the DNA, which are located adjacent to V, D, or J segments. The RAG complex cleaves the DNA between the signal sequences and the segments, enabling the segments to separate and move to different regions of the gene. This process is repeated multiple times in B cells and T cells, allowing V, D, and J segments to be arranged in different combinations. The resulting protein diversity provides a broader capability for recognizing foreign invaders and allows the body to effectively defend against infections. RAG2 not only participates in the catalysis of the reaction but also regulates the reaction by controlling access to specific genomic loci [6].
The hCRBN/Rag2-KO(BALB/c) mouse is a combined genetically modified model obtained by crossing hCRBN(BALB/c) mice (Catalog No.: C001724) with Rag2-KO(BALB/c) mice. The hCRBN/Rag2-KO(BALB/c) mouse can be used for screening, pharmacodynamic evaluation, safety evaluation, and mechanism of action studies of drugs targeting CRBN. Based on the Rag2 knockout background, this model is an immunodeficient mouse model with T and B cell deficiency, which can be used for broad research in various oncology and immunology fields, providing a preclinical research tool for exploring the role of CRBN-targeted intervention in the context of related diseases.
Reference
Barankiewicz J, Salomon-Perzyński A, Misiewicz-Krzemińska I, Lech-Marańda E. CRL4CRBN E3 Ligase Complex as a Therapeutic Target in Multiple Myeloma. Cancers (Basel). 2022 Sep 16;14(18):4492.
Zhou L, Xu G. The Ubiquitination-Dependent and -Independent Functions of Cereblon in Cancer and Neurological Diseases. J Mol Biol. 2022 Mar 15;434(5):167457.
An J, Zhang X. Crbn-based molecular Glues: Breakthroughs and perspectives. Bioorg Med Chem. 2024 Apr 15;104:117683.
Yamamoto J, Ito T, Yamaguchi Y, Handa H. Discovery of CRBN as a target of thalidomide: a breakthrough for progress in the development of protein degraders. Chem Soc Rev. 2022 Aug 1;51(15):6234-6250.
Thapa R, Bhat AA, Gupta G, Renuka Jyothi S, Kaur I, Kumar S, Sharma N, Prasad GVS, Pramanik A, Ali H. CRBN-PROTACs in Cancer Therapy: From Mechanistic Insights to Clinical Applications. Chem Biol Drug Des. 2024 Nov;104(5):e70009.
Schatz DG. V(D)J recombination. Immunol Rev. 2004 Aug;200:5-11.
Strain Strategy
The hCRBN/Rag2-KO(BALB/c) mouse is a genetically modified model generated by crossing hCRBN(BALB/c) mice (Catalog No.: C001724) with Rag2-KO(BALB/c) mice.

Figure 1. Gene editing strategy of hCRBN(BALB/c) mice. The exon 2 to partial intron 2 of mouse Crbn was replaced with Exon 2~11 of Human CRBN CDS-BGH pA cassette.

Figure 2. Gene editing strategy of Rag2-KO(BALB/c) mice. The mouse Rag2 gene is located on chromosome 2 and contains three exons. Both the start and stop codons are located on exon 3. The Rag2 gene knockout was achieved by targeting exon 3 using gene editing technology.
Application Area
Screening, pharmacodynamic evaluation, safety evaluation, and mechanism-of-action studies of drugs targeting the CRBN protein;
Screening, development, and preclinical efficacy evaluation of CRBN-based targeted protein degradation (TPD) therapies;
Research on the pathological mechanisms and therapeutic approaches for non-syndromic intellectual disability;
Research on the pathological mechanisms and therapeutic approaches for malignant hematological diseases such as multiple myeloma.
Related Resource
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
